<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37292374</PMID><DateRevised><Year>2023</Year><Month>06</Month><Day>12</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-2360</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in pediatrics</Title><ISOAbbreviation>Front Pediatr</ISOAbbreviation></Journal><ArticleTitle>Prevalence and associating factors of long COVID in pediatric patients during the Delta and the Omicron variants.</ArticleTitle><Pagination><StartPage>1127582</StartPage><MedlinePgn>1127582</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1127582</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fped.2023.1127582</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">The number of pediatric COVID-19 infections is increasing; however, the data on long COVID conditions in children is still limited. Our study aimed to find the prevalence of long COVID in children during the Delta and Omicron waves, as well as associated factors.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A single-center prospective cohort study was conducted. We included 802 RT-PCR-confirmed COVID-19 pediatric patients in the Delta and Omicron periods. Long COVID was defined as having symptoms for &#x2265;3 months after infection. Parents and/or patients were interviewed by phone. Multivariable logistic regression was performed to find associated factors with long COVID.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The overall prevalence of long COVID was 30.2%. The Delta period had more prevalence than the Omicron (36.3% vs. 23.9%). Common symptoms for patients 0-3 years' old were loss of appetite, rhinorrhea, and nasal congestion. Conversely, patients 3-18 years' old had hair loss, dyspnea on exertion, rhinorrhea, and nasal congestion. However, there was no significant negative impact on daily life. Most symptoms improved after a 6-month follow-up. Factors associated with long COVID-19 conditions were infection during the Omicron period (adjusted OR: 0.54; 95% CI: 0.39-0.74, <i>P</i>&#x2009;&lt;&#x2009;0.001), fever (adjusted OR: 1.49, 95% CI: 1.01-2.20, <i>P</i>&#x2009;=&#x2009;0.04) and rhinorrhea (adjusted OR: 1.47, 95% CI: 1.06-2.02, <i>P&#x2009;</i>=&#x2009;0.02).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Infection during the Omicron wave has a lower prevalence of long COVID. The prognosis is often favorable, and most symptoms gradually become less. However, pediatricians may schedule appointments to surveil long COVID in children with fever or rhinorrhea as an initial symptom.</AbstractText><CopyrightInformation>&#xa9; 2023 Lokanuwatsatien, Satdhabudha, Tangsathapornpong, Bunjoungmanee, Sinlapamongkolkul, Chaiyakulsil, Sritipsukho and Tantiyavarong.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lokanuwatsatien</LastName><ForeName>Tananya</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Thammasat University Hospital, Thammasat University, Pathum Thani, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Satdhabudha</LastName><ForeName>Araya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tangsathapornpong</LastName><ForeName>Auchara</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bunjoungmanee</LastName><ForeName>Pornumpa</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sinlapamongkolkul</LastName><ForeName>Phakatip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaiyakulsil</LastName><ForeName>Chanapai</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Thammasat University Hospital, Thammasat University, Pathum Thani, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sritipsukho</LastName><ForeName>Paskorn</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Excellence in Applied Epidemiology, Thammasat University, Pathum Thani, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tantiyavarong</LastName><ForeName>Pichaya</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Pediatr</MedlineTA><NlmUniqueID>101615492</NlmUniqueID><ISSNLinking>2296-2360</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Delta variant</Keyword><Keyword MajorTopicYN="N">Omicron variant</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>9</Day><Hour>4</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37292374</ArticleId><ArticleId IdType="pmc">PMC10244785</ArticleId><ArticleId IdType="doi">10.3389/fped.2023.1127582</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>She J, Liu L, Liu W. COVID-19 epidemic: disease characteristics in children. J Med Virol. (2020) 92(7):747&#x2013;54. 10.1002/jmv.25807</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25807</ArticleId><ArticleId IdType="pmc">PMC7228385</ArticleId><ArticleId IdType="pubmed">32232980</ArticleId></ArticleIdList></Reference><Reference><Citation>Say D, Crawford N, McNab S, Wurzel D, Steer A, Tosif S. Post-acute COVID-19 outcomes in children with mild and asymptomatic disease. Lancet Child Adolesc Health. (2021) 5(6):e22&#x2013;e3. 10.1016/S2352-4642(21)00124-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00124-3</ArticleId><ArticleId IdType="pmc">PMC8057863</ArticleId><ArticleId IdType="pubmed">33891880</ArticleId></ArticleIdList></Reference><Reference><Citation>Satdhabudha A, Chaiyakulsil C, Sritipsukho P, Sinlapamongkolkul P, Chaumrattanakul U, Tangsathapornpong A, et al. Epidemiological and clinical characteristics of pediatric COVID-19 in the tertiary care system in Thailand: comparative Delta and pre-Delta era. Mediterr J Hematol Infect Dis. (2022) 14(1):e2022044. 10.4084/MJHID.2022.044</Citation><ArticleIdList><ArticleId IdType="doi">10.4084/MJHID.2022.044</ArticleId><ArticleId IdType="pmc">PMC9084174</ArticleId><ArticleId IdType="pubmed">35615321</ArticleId></ArticleIdList></Reference><Reference><Citation>Khemiri H, Ayouni K, Triki H, Haddad-Boubaker S. SARS-CoV-2 infection in pediatric population before and during the Delta (B.1.617.2) and omicron (B.1.1.529) variants era. Virol J. (2022) 19(1):144. 10.1186/s12985-022-01873-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-022-01873-4</ArticleId><ArticleId IdType="pmc">PMC9452867</ArticleId><ArticleId IdType="pubmed">36076271</ArticleId></ArticleIdList></Reference><Reference><Citation>Torjesen I. COVID-19: omicron variant is linked to steep rise in hospital admissions of very young children. Br Med J. (2022) 376:o110. 10.1136/bmj.o110</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o110</ArticleId><ArticleId IdType="pubmed">35031537</ArticleId></ArticleIdList></Reference><Reference><Citation>Clements W, Joseph T, Koukounaras JJC. UK NICE guidelines for EVAR: cost implications for post-COVID Australian public health. J Vasc Interv Radiol. (2021) 44:1286&#x2013;8. 10.1007/s00270-021-02832-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00270-021-02832-2</ArticleId><ArticleId IdType="pubmed">33884459</ArticleId></ArticleIdList></Reference><Reference><Citation>Smane L, Roge I, Pucuka Z, Pavare J. Clinical features of pediatric post-acute COVID-19: a descriptive retrospective follow-up study. Ital J Pediatr. (2021) 47(1):177. 10.1186/s13052-021-01127-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13052-021-01127-z</ArticleId><ArticleId IdType="pmc">PMC8390049</ArticleId><ArticleId IdType="pubmed">34446085</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomson H. Children with long COVID. New Sci. (2021) 249(3323):10&#x2013;1. 10.1016/S0262-4079(21)00303-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0262-4079(21)00303-1</ArticleId><ArticleId IdType="pmc">PMC7927578</ArticleId><ArticleId IdType="pubmed">33686318</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Munblit D, De Rose C, Sinatti D, Ricchiuto A, Carfi A, et al. Preliminary evidence on long COVID in children. Acta Paediatr. (2021) 110(7):2208&#x2013;11. 10.1111/apa.15870</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15870</ArticleId><ArticleId IdType="pmc">PMC8251440</ArticleId><ArticleId IdType="pubmed">33835507</ArticleId></ArticleIdList></Reference><Reference><Citation>Corona Virus Disease (COVID-19). (2022). Available at: https://ddc.moph.go.th/viralpneumonia/eng/index.php</Citation></Reference><Reference><Citation>Department of Medical Science. SARS-CoV-2 variants in Thailand. (2023). Available at: https://dmsc.gdcatalog.go.th/dataset/sars-cov-2-variants</Citation></Reference><Reference><Citation>COVID-19 Treatment Guidelines (2022). (Available at: https://www.covid19treatmentguidelines.nih.gov/</Citation></Reference><Reference><Citation>COVID-19 Department of Medical Services. (2022) Available at: https://covid19.dms.go.th/</Citation></Reference><Reference><Citation>Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O'Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. (2019) 95:103208. 10.1016/j.jbi.2019.103208</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2019.103208</ArticleId><ArticleId IdType="pmc">PMC7254481</ArticleId><ArticleId IdType="pubmed">31078660</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)&#x2013;a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. (2009) 42(2):377&#x2013;81. 10.1016/j.jbi.2008.08.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2008.08.010</ArticleId><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Ayuzo Del Valle NC, Perelman C, Sepulveda R, Rebolledo PA, et al. Long-COVID in children and adolescents: a systematic review and meta-analyses. Sci Rep. 2022;12(1):9950. 10.1038/s41598-022-13495-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-13495-5</ArticleId><ArticleId IdType="pmc">PMC9226045</ArticleId><ArticleId IdType="pubmed">35739136</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise J. COVID-19: long COVID risk is lower with omicron than delta, researchers find. Br Med J. (2022) 377:o1500. 10.1136/bmj.o1500</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o1500</ArticleId><ArticleId IdType="pubmed">35714995</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Morello R, Mariani F, De Rose C, Mastrantoni L, Zampino G, et al. Risk of long COVID in children infected with omicron or pre-omicron SARS-CoV-2 variants. Acta Paediatr. (2023) 112(6):1284&#x2013;86. 10.1111/apa.16764</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.16764</ArticleId><ArticleId IdType="pubmed">36938946</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanov IM, Spiridonova E, Bobkova P, Gamirova A, Shikhaleva A, Andreeva M, et al. Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC global follow-up protocol: a prospective cohort study. Eur Respir J. (2022) 59(2):2101341. 10.1183/13993003.01341-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01341-2021</ArticleId><ArticleId IdType="pmc">PMC8576804</ArticleId><ArticleId IdType="pubmed">34210789</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise J. Long COVID: one in seven children may still have symptoms 15 weeks after infection, data show. Br Med J. (2021) 374:n2157. 10.1136/bmj.n2157</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n2157</ArticleId><ArticleId IdType="pubmed">34470745</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin LB, Weinstock LB, Molderings GJ. COVID-19 hyperinflammation and post-COVID-19 illness may be rooted in mast cell activation syndrome. Int J Infect Dis. (2020) 100:327&#x2013;32. 10.1016/j.ijid.2020.09.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7529115</ArticleId><ArticleId IdType="pubmed">32920235</ArticleId></ArticleIdList></Reference><Reference><Citation>Borch L, Holm M, Knudsen M, Ellermann-Eriksen S, Hagstroem S. Long COVID symptoms and duration in SARS-CoV-2 positive children - a nationwide cohort study. Eur J Pediatr. (2022) 181(4):1597&#x2013;607. 10.1007/s00431-021-04345-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-04345-z</ArticleId><ArticleId IdType="pmc">PMC8742700</ArticleId><ArticleId IdType="pubmed">35000003</ArticleId></ArticleIdList></Reference><Reference><Citation>Molteni E, Sudre CH, Canas LS, Bhopal SS, Hughes RC, Antonelli M, et al. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child Adolesc Health. (2021) 5(10):708&#x2013;18. 10.1016/S2352-4642(21)00198-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00198-X</ArticleId><ArticleId IdType="pmc">PMC8443448</ArticleId><ArticleId IdType="pubmed">34358472</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, Catahay JA, Velasco JV, Pastrana A, Ver AT, Pangilinan FC, et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: a systematic review. EClinicalMedicine. (2022) 53:101624. 10.1016/j.eclinm.2022.101624</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Byambasuren O, Stehlik P, Clark J, Alcorn K, Glasziou P. Effect of COVID-19 vaccination on long COVID: systematic review. BMJ Med. (2023) 2(1):e000385. 10.1136/bmjmed-2022-000385</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjmed-2022-000385</ArticleId><ArticleId IdType="pmc">PMC9978692</ArticleId><ArticleId IdType="pubmed">36936268</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>